Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
AuthorMeyerson, B E
Agley, J D
Eldridge, L A
AffiliationUniv Arizona, Coll Pharm
Univ Arizona, Southwest Inst Res Women
KeywordsConsolidated framework for implementation research
Opioid overdose reduction
MetadataShow full item record
PublisherELSEVIER SCIENCE INC
CitationMeyerson, B. E., Agley, J. D., Jayawardene, W., Eldridge, L. A., Arora, P., Smith, C., ... & PharmNet Research Team. (2019). Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2019.08.026
Rights© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractBackground: Evidence-based harm reduction intervention components which might benefit pharmacy patients have not been integrated and studied. Objective: To investigate the feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C called PharmNet. Methods: Indiana managing pharmacists were surveyed in 2018 to assess the feasibility and acceptability of an intervention for opioid misuse screening, brief intervention, syringe and naloxone dispensing, and referrals provision. The Consolidated Framework for Implementation Research informed the survey development and analysis. Results: The sample included 303 (30.8%) pharmacists; 215 (70.9%) provided detailed written comments. Intervention Characteristics: 83.3% believed PharmNet would benefit patients, and that staff could deliver the intervention with adequate training (70.0%). Inner Setting: While 77.2% believed their pharmacy culture supported practice change, 57.5% of chain pharmacists believed their pharmacies would not have time for PharmNet. Outer Setting: 73.3% believed additional addiction and overdose screening is needed in their community, and pharmacies should offer new services to help reduce opioid overdose and addiction among their patients (79.5%). A vast majority (97.7%) were asked by patients in the past 2 years about syringe related issues; 67.7% were asked about syringes for non-prescription injection drug use. Individuals Involved: While 62.4% believed PharmNet was within pharmacy scope of practice and 90.1% were comfortable consulting about syringe use, pharmacists reported that they had limited control over the implementation environment. Process: 38.0% of pharmacists indicated interest in advising the development of PharmNet. Conclusions: An implementation trial of a modified version of PharmNet is likely feasible; yet will be challenged by structural pressures particularly in chain pharmacies. Successful implementation will involve the development of resources and policy components to manage outer and inner setting characteristics and align the intervention to the implementation environment.
NoteOpen access article
VersionFinal published version
- Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
- Authors: Stopka TJ, Donahue A, Hutcheson M, Green TC
- Issue date: 2017 Mar - Apr
- Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.
- Authors: Meyerson BE, Davis A, Agley JD, Shannon DJ, Lawrence CA, Ryder PT, Ritchie K, Gassman R
- Issue date: 2018 Jun
- Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
- Authors: Nielsen S, Kowalski M, Wood P, Larney S, Bruno R, Shanahan M, Lenton S, Dietze P, Green T, Murnion B, Ritter A
- Issue date: 2019 Aug
- Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
- Authors: Bailey AM, Wermeling DP
- Issue date: 2014 May
- Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
- Authors: Skoy E, Eukel H, Werremeyer A, Strand M, Frenzel O, Steig J
- Issue date: 2020 Jan - Feb